Obesity and menstrual disorders.

Area of Science:

• Reproductive endocrinology
• Obesity medicine
• Women's health

Background:

• Obesity is linked to menstrual irregularities like oligomenorrhea and amenorrhea.
• The connection between obesity and heavy menstrual bleeding is not well-established, with limited prevalence data.
• Endometrial hyperplasia requires careful exclusion in obese women with menstrual disorders.

Purpose of the Study:

• To review current literature on menstrual disorders in obese women.
• To analyze the impact of body mass index (BMI) on treatment efficacy and adverse outcomes.
• To identify gaps in evidence and inform clinical practice for managing menstrual dysfunction in obesity.

Main Methods:

• Literature review of studies investigating menstrual disorders in obese women.
• Analysis of treatment strategies for menstrual irregularities in relation to BMI.
• Examination of effectiveness and adverse event data for various therapeutic options.

Main Results:

• Menstrual disorder investigation protocols for obese women are similar to normal-weight women, but endometrial hyperplasia screening is crucial.
• Treatment principles for menstrual disorders in obese women are generally consistent with those for normal-weight women.
• Therapeutic outcomes, including efficacy and adverse events, require careful consideration in high BMI populations.

Conclusions:

• Weight significantly influences the efficacy and safety of menstrual disorder treatments in obese women.
• Further research is needed to optimize management strategies for menstrual dysfunction in this population.
• Clinical practice should adapt to the unique challenges and considerations of treating obese women with menstrual disorders.